ArticleBiochemical pharmacology2013

The focal adhesion kinase inhibitor PF-562,271 impairs primary CD4+ T cell activation.

Andrew J Wiemer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.